Yahoo! Finance Search - Finance Home - Yahoo! - Help

Tuesday, December 2 2008 6:42am ET - U.S. Markets open in 2 hours and 48 minutes.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
View: Latest News | Top Stories
Tuesday, Dec 2, 2008
·Titan Pharmaceuticals Announces Reduction in Force
Business Wire - 12 minutes ago
·Nine Pharma Predictions for 2009
at Seeking Alpha - Tue 3:10 am ET
Monday, Dec 1, 2008
·QLT shares buck falling market on buyback
AP - Mon 7:06 pm ET
·Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
PR Newswire - Mon 7:01 pm ET
·ANA598 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C Infection
PR Newswire - Mon 6:38 pm ET
·Theravance Announces New Employment Inducement Awards
Marketwire - Mon 6:30 pm ET
·Enzon drops plan to spin off biotech business
AP - Mon 6:26 pm ET
·Lexicon files application for diabetes drug
AP - Mon 5:55 pm ET
·Final Glance: Biotechnology companies
AP - Mon 5:42 pm ET
·ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
PR Newswire - Mon 5:20 pm ET
·Emergent BioSolutions Looking Strong, Even on a Bad Day
at Seeking Alpha - Mon 5:06 pm ET
·Next-Generation Noninvasive Diagnostic Technology Shown to Accurately Detect Fetal Down Syndrome in First Trimester of Pregnancy
Business Wire - Mon 5:00 pm ET
·Enzon Discontinues Its Plan to Spin-off Its Biotechnology Business
Business Wire - Mon 4:49 pm ET
·Lexicon Files Investigational New Drug Application for LX4211 as a Potential Treatment for Diabetes
GlobeNewswire - Mon 4:30 pm ET
·Medicis and IMPAX Announce R&D Collaboration and Settlement
GlobeNewswire - Mon 4:05 pm ET
·Dynamics Group AG Publishes Research Report on Senetek
PR Newswire - Mon 4:05 pm ET
·Cytokinetics Announces Clinical Trial Data Regarding SB-743921 to Be Presented at the 2008 American Society of Hematology Annual Meeting and Exposition
Marketwire - Mon 4:00 pm ET
·[external] A Better Way to Invest in Biotech?
at Motley Fool - Mon 3:46 pm ET
·Sales of Sinovac's Hepatitis Vaccine Suspended Following Baby's Death
at Seeking Alpha - Mon 2:45 pm ET
·Predictions: 9 For '09 In Pharma
at CNBC - Mon 2:00 pm ET
More Latest News...
Sponsor Results
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial.
www.GFTforex.com
Countrywide® Home Loans
No Cash Required For Closing Costs. Call Or Apply Online Now.
www.Countrywide.com
Try Forex Currency Trading at Forex.com
Free $50,000 practice account with real-time charts, news and research.
www.forex.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Biotechnology Headlines
More Finance RSS Feeds

Copyright © 2008 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2008 Morningstar, Inc. All Rights Reserved. Company information © 2008 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2008, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.
Questions or Comments?